1. In this randomized controlled trial, there was a significant reduction in the Disease Activity Score of rheumatoid arthritis patients ...
1. In this randomized controlled trial, there was a significant reduction in the Disease Activity Score of rheumatoid arthritis patients ...
1. In this randomized controlled trial, there was a significant reduction in the Disease Activity Score of rheumatoid arthritis patients ...
1. Prasinezumab had no meaningful effect on global or imaging measures of Parkinson’s disease progression. 2. Prasinezumab therapy was associated ...
1. Litifilimab significantly decreased cutaneous lupus erythematosus (CLE) disease area and severity index scale (CLASI-A) after 16 weeks of treatment. ...
